New immunotherapy treatments offer a remarkable chance for survival for patients with advanced melanoma and hard-to-treat cancers of the bladder, kidney and lung. But the treatments, designed to unleash the immune system to attack cancer, can also spur an assault on healthy organs, including the eye. The cases of three recent patients, published by University